Search Results

Switching from IV to oral ciprofloxacin achieves similar response rates to IV treatment alone in spontaneous bacterial peritonitis

Source: Inpharma, Volume 1, Number 1260, 2000 , pp. 14-14(1)

Publisher: Adis International

IV-to-oral ciprofloxacin switch cost saving

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 285, 2000 , pp. 11-11(1)

Publisher: Adis International

IV-to-Oral Switch Therapy with Trovafloxacin Compared with IV Ceftazidime/Oral Ciprofloxacin in the Treatment of Nosocomial Pneumonia

Authors: Bassaris H.P.; Hopkins D.W.; Daniel R.

Source: Drugs, Volume 58, Supplement 2, 1999 , pp. 309-311(3)

Publisher: Adis International

Trovafloxacin vs Ciprofloxacin ± Clindamycin/Metronidazole in Patients with Nosocomial Pneumonia

Authors: Hopkins D.W.; Daniel R.

Source: Drugs, Volume 58, Supplement 2, 1999 , pp. 323-325(3)

Publisher: Adis International

Development of High Level Quinolone Resistance in Streptococcus pneumoniae During Sequential Quinolone Therapy

Authors: Suh B.; Lorber B.; Gelone S.; Truant A.L.; Gootz T.D.

Source: Drugs, Volume 58, Supplement 2, 1999 , pp. 383-384(2)

Publisher: Adis International

Cost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections

Authors: Walters D.J.; Solomkin J.S.; Paladino J.A.

Source: PharmacoEconomics, Volume 16, Number 5, November 1999 , pp. 551-561(11)

Publisher: Adis International

A Critical Pathway for the Treatment of Community-Acquired Pneumonia

Authors: Marrie T.J.; Lau C.Y.; Wheeler S.L.; Wong C.J.; Vandervoort M.K.; Feagan B.G.

Source: Drugs, Volume 58, Supplement 2, 1999 , pp. 273-275(3)

Publisher: Adis International